Syros Pharmaceuticals: Q1 Earnings Insights

Syros Pharmaceuticals SYRS reported its Q1 earnings results on Wednesday, May 10, 2023 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Syros Pharmaceuticals beat estimated earnings by 22.02%, reporting an EPS of $-0.85 versus an estimate of $-1.09.

Revenue was down $2.51 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $1.18 which was followed by a 4.52% increase in the share price the next day.

To track all earnings releases for Syros Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.